Fintel reports that on January 23, 2025, Piper Sandler initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) with a ...

Don Schneider, Piper Sandler deputy head of U.S. policy, and Marc Goldwein, CRFB SVP and senior policy director, join CNBC's ...

Piper Sandler analyst Andrew Liesch maintained a Buy rating on Equity Bancshares (EQBK – Research Report) today and set a price target of ...

Piper Sandler analyst Derek Podhaizer maintained a Buy rating on Halliburton (HAL – Research Report) today and set a price target of $36.00.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

ChampionX Corp (CHX) stock saw a decline, ending the day at $29.69 which represents a decrease of $-1.58 or -5.05% from the prior close of $31.27. The stock opened at $31.08 and touched a low of ...

Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a ...

Tesla (TSLA) slips as President Trump considers eliminating EV tax credits and subsidies, while Piper Sandler analysts raise ...

Piper Sandler downgraded Biogen (NASDAQ:BIIB) to neutral from overweight on Thursday, citing, among other things, the company's challenges in establishing its presence in the market for Alzheimer ...

Tesla shares TSLA ended the day down 0.6%, after falling as much as 4% intraday, tracking losses in the broader EV space, ...